LifePlus announced five clinical trials around the world are being performed to evaluate its LifeLeaf noninvasive continuous blood glucose monitoring multi-sensor wearable, which also monitors blood pressure, heart rate, oxygen saturation and respiration rate. The multi-sensor watch also noninvasively and continuously tracks chronic conditions, such as diabetes, congestive heart failure and hypertension, and provides users with cloud-based artificial intelligence solutions and notifications in real time.
LifePlus' CGM multi-sensor watch being tested in 5 trials
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.